Gemcitabine in Combination with the Oral Irreversible ErbB Inhibitor Afatinib versus Gemcitabine Alone in Patients with Metastatic Pancreatic Cancer: an Explorative Randomized Phase II Trial
(Bauchspeicheldrüse, Pankreaskarzinom, Bauchspeicheldrüsenkarzinom, Pankreasmalignom, Pankreatoblastom)